Atomwise IPO

atomwise.com

Atomwise is the developer of first deep learning technology designed for structure-based small molecule drug discovery.

Founded2012
Total Funding to Date$151.49MM
Register for Details

For more details on financing and valuation for Atomwise, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Atomwise Ticker Symbol

Atomwise does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Atomwise Stock Price

The stock price for Atomwise will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Atomwise Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/11/2020 Series B $405.17MM $XXX.XX $XXX.XX
3/7/2018 Series A-1 $157.27MM $XXX.XX $XXX.XX
6/3/2015 Series A-8 $21.21MM $XXX.XX $XXX.XX
3/23/2015 Series A-2, A-3, A-4, A-5, A-6, and A-7 $5.91MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Atomwise in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B